Key facts
- Ph.D. Ronald A. Pepin has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $55,869.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Ph.D. Ronald A. Pepin
- Location
- Hampton, NJ
- Summary
- The estimated net worth of Ph.D. Ronald A. Pepin is at least $55,869 dollars as of 17 Dec 2025. Ph.D. Ronald A. Pepin is the SR. VP & CBO of Celldex Therapeutics, Inc. and owns shares of Celldex Therapeutics, Inc. (CLDX) stock worth about $55.9K.
- Signature
- /s/ Sam Martin, attorney-in-fact for Ronald A. Pepin, Ph.D.
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Ph.D. Ronald A. Pepin and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Change
- Largest disclosed position: Celldex Therapeutics, Inc. ($55,869).
- Past-year value change for that position: .
Research use
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Ph.D. Ronald A. Pepin
CLDX
Forms 3/4/5
Celldex Therapeutics, Inc.
- Relationship
- Sr. Vp & Cbo
- Holdings value
- $55,869
- Past year net change
- Change %
- Report period
- 15 Dec 2025
Insider Transactions Reported by Ph.D. Ronald A. Pepin:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.